. Table 1 : Sales Revenue by Product Line for the Three Months period ended 30 June (3M YoY) Sales by geography Consolidated financial statements Change Increase/(Decrease) For Three Months Period Ended 30
results for the 3-month period ending 31 March 2020 and 2019 (Unit: Thousand Baht) Consolidated Financial Statements Increase (Decrease) Separate Financial Statements Increase (Decrease) 2020 2019 Thousand
digit driven by all business segments. EBITDA margin is expected to be stable while budgeted for CAPEX of Bt20-25bn (see guidance on page 6). Significant Event for FY19 Since 1 January 2019, AIS has
hereby clarifies the changes in the performance as follows: FINANCIAL PERFORMANCE Consolidated Financial Statements 2016 2017 Increase/(Decrease) THB mm THB mm THB mm % Total Revenue/1 19,325.0 12,410.0
consolidated financial statements decreased by Baht 70.97 million or 2.46% compared with last year. A decrease mainly caused by trade accounts receivable of Baht 54.17 million. Decrease in cash and cash
Overview In the year 2017, the overall picture of the apparel industry remained stable in line with the Thai and global economy. The sale of goods to foreign countries has been affected by the appreciation
-agricultural sector, which was partly supported by government measures. Although the number of overseas tourists was stable, there was a decline in the export sector which has been affected by the trade dispute
17.74% 20.03 9.21% 49.42 246.73% Jul – Sep 63 Jul – Sep 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขที่ 111 หมู่ที่ 2 ตาํบลท่าจนี อาํเภอเมืองสมุทรสาคร จงัหวดัสมุทรสาคร 74000 111 Moo 2
year 2018 amounted to THB 836 million which loss higher than last year mainly due to HRC selling price is stable whilst the cost for import scraps is continuous increase. However, for the year 2018, the
the year 2018 amounted to THB 836 million which loss higher than last year mainly due to HRC selling price is stable whilst the cost for import scraps is continuous increase. However, for the year 2018